PD-L1 levels have been evaluated in tumors treated with ipilimumab in metastatic or recurrent cervical cancer patients who had progression after at least one line of platinum chemotherapy with pelvic radiotherapy (30). The gene discussed is CD274; the disease is cervical carcinoma.